Destination Maternity Corp (DEST) 13.42 $DEST 24.8%

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Destination Maternity Corp (DEST) 13.42 $DEST

24.8% Return Seen to Date on SmarTrend Destination Maternity Call (DEST)
Comtex SmarTrend(R) - Wed Apr 22, 9:46AM CDT
SmarTrend identified a Downtrend for Destination Maternity (NASDAQEST) on July 30th, 2014 at $18.56. In approximately 9 months, Destination Maternity has returned 24.82% as of today's recent price of $13.95.
DEST: 13.42 (-0.57)

Destination Maternity Shares Down 22.5% Since SmarTrend's Sell Call (DEST)
Comtex SmarTrend(R) - Wed Apr 15, 9:20AM CDT
SmarTrend identified a Downtrend for Destination Maternity (NASDAQEST) on July 30th, 2014 at $18.56. In approximately 9 months, Destination Maternity has returned 22.50% as of today's recent price of $14.38.
DEST: 13.42 (-0.57)

Downtrend Call Working As Destination Maternity Stock Falls 19.2% (DEST)
Comtex SmarTrend(R) - Tue Apr 07, 4:50PM CDT
SmarTrend identified a Downtrend for Destination Maternity (NASDAQEST) on July 30th, 2014 at $18.56. In approximately 8 months, Destination Maternity has returned 19.16% as of today's recent price of $15.00.
DEST: 13.42 (-0.57)

Shares of DEST Down 19.6% Since Downtrend Call on Shares
Comtex SmarTrend(R) - Tue Mar 31, 11:23AM CDT
SmarTrend identified a Downtrend for Destination Maternity (NASDAQEST) on July 30th, 2014 at $18.56. In approximately 8 months, Destination Maternity has returned 19.64% as of today's recent price of $14.91.
DEST: 13.42 (-0.57)

Destination Maternity Down 17.2% Since SmarTrend Downtrend Call (DEST)
Comtex SmarTrend(R) - Tue Mar 24, 9:48AM CDT
SmarTrend identified a Downtrend for Destination Maternity (NASDAQEST) on July 30th, 2014 at $18.56. In approximately 8 months, Destination Maternity has returned 17.17% as of today's recent price of $15.37.
DEST: 13.42 (-0.57)

Destination Maternity's (DEST) CEO, Anthony Romano on Q1 2015 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Mar 12, 10:02AM CDT

DEST: 13.42 (-0.57)

Destination Maternity (DEST) Q1 2015 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Thu Mar 12, 7:55AM CDT

DEST: 13.42 (-0.57)

Destination Maternity reports four month results
Seeking Alpha - at Seeking Alpha - Thu Mar 12, 6:39AM CDT

DEST: 13.42 (-0.57)

Inventory misfires hit Destination Maternity
Seeking Alpha - at Seeking Alpha - Thu Mar 12, 6:04AM CDT

DEST: 13.42 (-0.57)

Destination Maternity Reports Financial Results For The Four Months Ended January 31, 2015
PR Newswire - Thu Mar 12, 5:00AM CDT
Destination Maternity Corporation (NASDAQ: DEST), the world's leading maternity apparel retailer, today announced results for the four month period ended January 31, 2015. The four month period from October 1, 2014 to January 31, 2015 represents the transition period related to the Company's previously announced fiscal year-end change from September 30 to the Saturday nearest January 31 of each year. On February 25, 2015 the Company announced that its Board of Directors declared a regular quarterly cash dividend of $0.20 per share payable March 27, 2015.
DEST: 13.42 (-0.57)

11.5% Return Seen to Date on SmarTrend Destination Maternity Call (DEST)
Comtex SmarTrend(R) - Mon Mar 09, 5:07PM CDT
SmarTrend identified a Downtrend for Destination Maternity (NASDAQEST) on July 30th, 2014 at $18.56. In approximately 7 months, Destination Maternity has returned 11.45% as of today's recent price of $16.43.
DEST: 13.42 (-0.57)

Destination Maternity Corporation to Present at the ROTH 27th Annual Conference on March 9th
PR Newswire - Mon Mar 02, 1:59PM CST
Destination Maternity Corporation (Nasdaq: DEST), the world's leading maternity apparel retailer, today announced that members of its senior management will present to investors at the ROTH 27th Annual Conference on Monday, March 9, 2015, at 10:00 a.m. Pacific Time at The Ritz Carlton in Dana Point, CA.
DEST: 13.42 (-0.57)

Destination Maternity declares $0.20 dividend
Seeking Alpha - at Seeking Alpha - Wed Feb 25, 5:18AM CST

DEST: 13.42 (-0.57)

Destination Maternity Shares Down 13.8% Since SmarTrend's Sell Call (DEST)
Comtex SmarTrend(R) - Fri Feb 06, 9:31AM CST
SmarTrend identified a Downtrend for Destination Maternity (NASDAQEST) on July 30th, 2014 at $18.56. In approximately 6 months, Destination Maternity has returned 13.82% as of today's recent price of $15.99.
DEST: 13.42 (-0.57)

Destination Maternity Has Returned 16.2% Since SmarTrend Recommendation (DEST)
Comtex SmarTrend(R) - Thu Jan 29, 5:07PM CST
SmarTrend identified a Downtrend for Destination Maternity (NASDAQEST) on July 30th, 2014 at $18.56. In approximately 6 months, Destination Maternity has returned 16.20% as of today's recent price of $15.55.
DEST: 13.42 (-0.57)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

First Industrial Declares Regular Dividend Amid Growth Insights

Updated Category News Views 75

Dividend Declaration Reflects Confidence First Industrial Realty Trust, folks, just put another office stamp on their ongoing reliability quest—and I'm talking dividends. They're shelling out a tidy $0.50 per share for Q4 2026, with stockholders due to see the cash on January 19, 2027. That's like clockwork precision, showing a steadiness in what some call the unruly...

Continue Reading
Trimble's Q3 2026: Guidance Update and Record ARR

Updated Category News Views 48

Trimble Smashes Through Q3 Expectations Trimble Inc. (NASDAQ:TRMB) tossed a bit of a curveball by posting Q3 2026 results that sailed past analyst forecasts. We’re talking revenue swelling to $966.8 million, a decent 7% bump from the previous year. Now, for a company riding its 'Connect & Scale' strategy, this serves as a validation of its aggressive scaling ambitions....

Continue Reading
Fractal Sees Explosive Q2 Gain: Revenue Hits $100M

Updated Category News Views 93

Fractal’s Revenue Moment: Climbing New Peaks Fractal Analytics just knocked it out of the park, folks. Imagine this—an AI company pulling in $100 million for the first quarter, getting a 20% jump in revenue year on year. That's right, these numbers aren't just fancy figures; they're staggering proof that Fractal's hitting its AI stride. The healthcare and life...

Continue Reading
Zuellig Pharma Expands Clinical Capabilities in China

Updated Category News Views 86

Zuellig Pharma's Strategic Leap in Hangzhou You know, in the ever-evolving world of biotech and pharmaceuticals, setting up shop in the right locale can mean the difference between breakthroughs and breakdowns. So Zuellig Pharma—a major player, but not exactly a household ticker—made a smart move acquiring a clinical facility in Hangzhou. This is no minor shuffle;...

Continue Reading
Natixis' $100M Student Challenge Mixes Real Stakes

Updated Category News Views 56

Opportunity Knocks for Budding Portfolio Managers Picture this: You're a student, neck-deep in textbooks and theories, and then bam! You're handed the keys to manage a $100 million portfolio. That's the real-deal opportunity Natixis Investment Managers is dangling with its seventh Students Challenge. Diving Into the Nuts and Bolts Listen up, kids. Applications are open...

Continue Reading
VAB's Pharma Ad Guide: Emerging Trends and Insights

Updated Category News Views 191

Pharma's not just popping pills anymore; it's a whole show on multiscreen TV. The Video Advertising Bureau (VAB) just dropped a bombshell of a guide called The Pharmacy, diving into the state of pharmaceutical direct-to-consumer (DTC) advertising. Over the past year and a half, VAB's been grilling agencies, media folks, and anyone else with skin in the game to sketch the...

Continue Reading
Coretek Joins CRN's Elite AI Innovators of 2026

Updated Category News Views 69

Coretek's Leap to AI Innovator Status Here we are, folks. Another announcement hits the wires that showcases a company's ascent amid the swelling AI tide. Coretek, hailing from Farmington Hills, managed to snag a spot on CRN's inaugural 2026 AI Innovators list. No small potatoes, if you ask me, considering the competition on this playing field. Why the fuss? It's about...

Continue Reading
Allego Dominates 2026 Gartner Magic Quadrant: Why It Matters

Updated Category News Views 40

Allego Secures Top Spot Yet Again I've seen companies rise and fall on the whims of industry recognition, and let me tell ya, Allego's riding high on the right wave. For the second year running, this outfit's been named a Leader in the 2026 Gartner Magic Quadrant for Revenue Enablement Platforms. Recognized for its Completeness of Vision—yeah, that's no small feat...

Continue Reading
KOVE's Bold Lineup Expansion at EICMA 2026

Updated Category News Views 112

What's Roaring: The Latest from KOVE Anybody who’s been following motorcycle trends knows that EICMA 2026 was destined to be a spectacle, and KOVE didn’t disappoint. They rolled out a fleet of five new models, including the 125 RALLY, 350 RALLY, 650RR, and two head-turners on the electric front: the BONIC and the E-500RR. Each model brings something fresh to the...

Continue Reading
Askey & Icom Team Up: Trading Airwaves for Partnerships

Updated Category News Views 6

Old-School Radios Meet Cutting-Edge 5G When I hear about a company linking their old-school tech with shiny new 5G jazz, skepticism kicks in fast. But then comes this announcement: Askey and Icom America are joining forces to bring 5G networks with integrated two-way radio systems to various sectors—like a classic combo meal with a tech twist. The key audience? Utility...

Continue Reading

Top 5 Most Recently Viewed Articles

Tesla's Earnings Impact: A Preview for Investors Ahead

Updated Category News Views 206

Tesla's Earnings and Market Dynamics As we gear up for Tesla's earnings announcement, all eyes are turning to the electric vehicle giant (NASDAQ: TSLA). Tesla is leading the charge as the first among the prominent group of tech companies known as the "Magnificent Seven" to reveal its financial performance. The anticipation builds as markets reflect on how business...

Continue Reading
Atos Group Releases Detailed Half-Year Financial Report for 2025

Updated Category News Views 222

Atos Group Updates on Financial Performance for 2025 Availability of the 2025 Half-year Financial Report Atos Group has made significant strides in its financial reporting for 2025, announcing the release of its half-year financial report. This document was published on the Atos website and was also filed with the French Financial Markets Authority (AMF). Insights from...

Continue Reading
Anywhere Real Estate and Canva Team Up for Agents' Success

Updated Category News Views 204

Anywhere Real Estate's Exciting New Partnership Anywhere Real Estate Inc. (NYSE: HOUS), a global frontrunner in the residential real estate sector, has recently unveiled an impactful collaboration with Canva, a recognized visual communication platform. This agreement aims to empower Every agent within their extensive network. Enhanced Tools for Affiliated Agents This...

Continue Reading
THEON Showcases Innovative A.R.M.E.D. Ecosystem at IDEX 2025

Updated Category News Views 279

THEON Unveils Revolutionary A.R.M.E.D. Ecosystem At IDEX 2025, THEON made a significant impact by showcasing its A.R.M.E.D. (Augmented Reality Modular Ecosystem of Devices), designed to elevate the capabilities of tomorrow's soldiers. This integrated solution promises to improve tactical awareness, effectiveness, and survivability for modern combat operatives....

Continue Reading
Exploring Advances in Arthrogryposis at Montreal Symposium

Updated Category News Views 304

4th International Symposium on Arthrogryposis Unveiled in Montreal MONTREAL — The Shriners Hospitals for Children - Canada is set to host the much-anticipated 4th International Symposium on Arthrogryposis from September 28 to October 1. This initiative brings together renowned healthcare professionals and researchers from various pediatric centers in Montreal,...

Continue Reading